Rare somatic cells from human breast tissue exhibit extensive lineage plasticity

We identified cell surface markers associated with repression of p16 ᴵᴺᴷ⁴ᵃ/cyclin-dependent kinase inhibitor 2A(CDKN2A), a critical determinant in the acquisition of a plastic state. These cell surface markers allowed direct isolation of rare cells from healthy human breast tissue that exhibit exten...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 110; no. 12; pp. 4598 - 4603
Main Authors Roy, Somdutta, Gascard, Philippe, Dumont, Nancy, Zhao, Jianxin, Pan, Deng, Petrie, Sarah, Margeta, Marta, Tlsty, Thea D.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 19.03.2013
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We identified cell surface markers associated with repression of p16 ᴵᴺᴷ⁴ᵃ/cyclin-dependent kinase inhibitor 2A(CDKN2A), a critical determinant in the acquisition of a plastic state. These cell surface markers allowed direct isolation of rare cells from healthy human breast tissue that exhibit extensive lineage plasticity. This subpopulation is poised to transcribe plasticity markers, OCT3/4, SOX2, and NANOG, at levels similar to those measured in human embryonic stem cells and to acquire a plastic state sensitive to environmental programming. In vitro, in vivo, and teratoma assays demonstrated that either a directly sorted (uncultured) or a single-cell (clonogenic) cell population from primary tissue can differentiate into functional derivatives of each germ layer, ectodermal, endodermal, and mesodermal. In contrast to other cells that express OCT3/4, SOX2, and NANOG, these human endogenous plastic somatic cells are mortal, express low telomerase activity, expand for an extensive but finite number of population doublings, and maintain a diploid karyotype before arresting in G1.
Bibliography:http://dx.doi.org/10.1073/pnas.1218682110
Edited* by Joan S. Brugge, Harvard Medical School, Boston, MA, and approved January 18, 2013 (received for review October 31, 2012)
Author contributions: S.R., P.G., and T.D.T. designed research; S.R., N.D., J.Z., D.P., and S.P. performed research; S.R., P.G., M.M., and T.D.T. analyzed data; and S.R., P.G., and T.D.T. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1218682110